Combination of H1 and H2 Histamine Receptor Antagonists: Current Knowledge and Perspectives of a Classic Treatment Strategy
Open Access
Abstract
Histamine receptor antagonists, which can bind to specific histamine receptors on target cells, exhibit substantial therapeutic efficacy in managing a variety of histamine-mediated disorders. Notably, histamine H1 and H2 receptor antagonists have been extensively investigated and universally acknowledged as recommended treatment agents for numerous allergic diseases and acid-related disorders, respectively. Historically, the combination of H1 and H2 receptor antagonists has been considered a classic treatment strategy, demonstrating relatively superior efficacy compared with single-drug therapies in the treatment of diverse histamine-mediated diseases. The latest emerging studies have additionally suggested the underlying roles of histamine and H1R and H2R in the development of anxiety disorders, arthritic diseases, and postexercise hypotension. Nevertheless, there is still a lack of systematic reviews on the clinical efficacy of combination therapy, greatly limiting our understanding of its clinical application. Here, we present a comprehensive overview of the current knowledge and perspectives regarding the combination of H1 and H2 histamine receptor antagonists in various histamine-mediated disorders. Furthermore, we critically analyze the adverse effects and limitations associated with combination therapy while suggesting potential solutions. Our review can offer a systematic summary and promising insights into the in-depth and effective application of the combination of H1 and H2 receptor antagonists.Keywords
Funding Information
- Shanghai Collaborative Innovation Project (XTCX-KJ-2023-44, 32201251, Basic scientific research project of Naval Medical University)
- National Natural Science Foundation of China (XTCX-KJ-2023-44, 32201251, Basic scientific research project of Naval Medical University)
- Basic scientific research project of Naval Medical University (XTCX-KJ-2023-44, 32201251, Basic scientific research project of Naval Medical University)
This publication has 95 references indexed in Scilit:
- Histamine stimulates the proliferation of small and large cholangiocytes by activation of both IP3/Ca2+ and cAMP-dependent signaling mechanismsLaboratory Investigation, 2011
- Inhibition of histidine decarboxylase ablates the autocrine tumorigenic effects of histamine in human cholangiocarcinomaGut, 2011
- Newly diagnosed and relapsed epithelial ovarian carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-upAnnals of Oncology, 2010
- Histamine H3-receptor signaling in cardiac sympathetic nerves: Identification of a novel MAPK-PLA2-COX-PGE2-EP3R pathwayBiochemical Pharmacology, 2007
- The effects of histaminergic agents in the dorsal hippocampus of rats in the elevated plus-maze test of anxietyPharmacology Biochemistry and Behavior, 2006
- Improved outcomes in patients with acute allergic syndromes who are treated with combined H1 and H2 antagonistsAnnals of Emergency Medicine, 2000
- Effect of H1and H2Antagonists on Nasal Symptoms and Mediator Release in Atopic Patients after Nasal Allergen Challenge during the Pollen SeasonActa Oto-Laryngologica, 1996
- Histamine antagonists in the treatment of acute allergic reactionsAnnals of Emergency Medicine, 1992
- H1‐ and H2‐antagonists in allergic and pseudoallergic diseasesClinical & Experimental Allergy, 1990
- H2 Blockers in Chronic UrticariaInternational Journal of Dermatology, 1984